Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INVESTED: High-Dose vs Standard-Dose Flu Vaccine in CV Patients
NCT02787044Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Aug 2016
- Primary completion
- May 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 4 trial of influenza virus vaccine, split virion in influenza, sponsored by Brigham and Women's Hospital. Started Aug 2016; status: completed.
02
Drugs
influenza virus vaccine, split virion
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02787044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02787044.